Vivos Therapeutics, Inc. has announced its plans to hold the 2024 Annual Meeting of Stockholders on November 26, 2024. The record date for stockholders entitled to vote at the meeting has been set for October 4, 2024. The company has also provided revised deadlines for stockholder proposals for the upcoming annual meeting. Proposals must be received by September 27, 2024, to be considered for inclusion in the proxy materials. This announcement follows the adjustment of the annual meeting's scheduled date, which is more than 30 days after the previous year's meeting, rendering prior deadlines for proposal submissions inapplicable. The company's definitive proxy statement will detail the time and location of the meeting and will be filed with the SEC. All submissions must adhere to the company's Amended and Restated Bylaws and SEC Rule 14a-8 requirements.

Vivos Therapeutics, Inc. has announced its plans to hold the 2024 Annual Meeting of Stockholders on November 26, 2024. The record date for stockholders entitled to vote at the meeting has been set for October 4, 2024. The company has also provided revised deadlines for stockholder proposals for the upcoming annual meeting. Proposals must be received by September 27, 2024, to be considered for inclusion in the proxy materials. This announcement follows the adjustment of the annual meeting's scheduled date, which is more than 30 days after the previous year's meeting, rendering prior deadlines for proposal submissions inapplicable. The company's definitive proxy statement will detail the time and location of the meeting and will be filed with the SEC. All submissions must adhere to the company's Amended and Restated Bylaws and SEC Rule 14a-8 requirements.